蒙娜麗莎(002918.SZ):擬開展應收賬款保理業務 保理融資金額總計不超10億元
格隆匯12月28日丨蒙娜麗莎(002918.SZ)公佈,公司於2020年12月28日召開了第二屆董事會第三十一次會議及第二屆監事會第二十三次會議決,分別審議通過了《關於開展應收賬款保理業務的議案》,根據實際經營需要,公司及合併範圍內子公司、孫公司擬與國內商業銀行、商業保理公司等具備相關業務資格的機構開展應收賬款保理業務,保理融資金額總計不超過人民幣10億元,保理業務申請期限自審議本議案股東大會決議通過之日起至下一年度審議保理融資額度的股東大會決議通過之日,具體每筆保理業務期限以單項保理合同約定期限為準。公司董事會提請股東大會授權公司管理層行使具體操作決策權並簽署相關法律文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.